Promoter collection, Human MMP2 promoter
Alternative name | U2667 (2045)-1 |
---|---|
Clone info. | PCR amplified human MMP2 promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 55470229 to 55479221(NC_000016.10); relatively -8969 to +24, where +1 corresponds to 1 nt of NM_004530.6. |
Comment | PCR cloning, forward primer: ctgcctcagcctcctgagta; reverse primer: cgcctgaggaagtctggat. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human matrix metallopeptidase 2 genomic DNA |
Depositor|Developer | DNA Bank, | Pan, Jianzhi | |
Remarks, protocol and/or map (pdf) | RDB07314.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07314 | pGL4-phMMP2 | DNA solution |
Materials & Methods section:
The pGL4-phMMP2 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07314). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB12746_A4D2.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: Sequence file: RDB12746_A4D2a.seq |
---|
>07314_12746_A4D2_pGL4-4174F_A11_02.ab1 1 AGGTGGGTTC CCGGAAAATT TCTCTGGCCT AACTGGCCGG TACCTGAGCT CGCTAGCCTC 61 GAGGATTTCC TCAGAGCCGG TTGTCACAGG GAGAACTTCA AAATTGGGAT TCGACCTGAG 121 AGGCCACATG GATTCTTGGC TTGGCGCAGG AAAGGATTCA AGAGTGAGTG GGGAATTCGT 181 GGAACTGAGG GCTCCTCCCC TTTTTAGACC ATATAGGGTA AACCTCCCCA CATTGCCATG 241 GCATTTATAC ACTGCCATGG CACTGGTGGG TGCTTCCTTT AACATGCTAA TGCATTATAA 301 TTAGCGTAAA ATGAGCAGTG AGGATGACCA GAGGTCGCTT TCTTTGCCAT CTTGGTTTTG 361 GCTGGCTTCT TCACTGCATA CTGTTTTATC AGTGGGGTCT TTGTGACCTC TATCTTATTA 421 AACCAGTCTT GCCCAATTTC TATCTCATCC TGTGACCGAG AATGCGGACC CTCCTGGGAG 481 TGCAGCCCAG CAGGTCTCAG CCTCATTTTA CCCAGCCCCC TGTTCAAGAT GGAGTCGCTC 541 TGGTTCCAAC GTCTCTAACG CGGGGCCCCT GACTGCTCTA TTTCCCAAGG TGTATCTAGC 601 ATCTCGCACT ATACGAGGCC AAGTTAAGGC TTACACATTT GCAGAAGGAA AGAGGTAAGG 661 AAGCAACCTG GGACCTTCCA CTGTCTCTGT TTCCATCTCT CTCTTTCCAT CTCTGTTCAT 721 CCCAGAATCT CTCTGTCCCT ATCCCTAAAT ATCGAAAATT TCTGTCTCTG ACCATCTATC 781 ATTGTGGCTG ATCATCTGTT TCTGACCATT CCTTCCCGTT CCTGACCCCA GGGAGTGCAG 841 GGTGTCCTAG CCAAGCCGGC GTCCCTCCTA GTAGTACCGC TGCTCTCTAA CCTCAGGACG 901 TCAAAGGGCC TAGAGCGACA GATGTTTCCC AGCAGGGGGT TCTGAGGCTG TGCGCCCAGA 961 TCGCGAGAGA GGGCAAGTGG GGGTGACGAG GTCGTGCACT GAGGGTGGAC GTAGAGGCCC 1021 AGGAGTAGCA GGCGGGCCGG GGGAAAAGAG TGGAGAAAGG AAAAAAGGAG GAGAAAGTGG 1081 AGGGAGGGCG AGTAAGGGGG GGGGTGGGGG GGCCAGAAAG GAGAGGGCCC // |
Primer: Sequence file: RDB12746_A4D2b.seq |
>07314_12746_A4D2_pGL4-136R_G11_20.ab1 1 CTTTAGTTGT TTTTTGGGCA TCTTCCATGG TGGCTTTACC AACAGTACCG GATTGCCAAG 61 CTTGGCCGCC GAGGCCAGAT CTTGATCGCC TGAGGAAGTC TGGATGCAGC GGAAACAAGG 121 GAGGGCAGCC GCCAGATGTA GCCGGCTGGG CTGGGAGGGA GCTGGCAGAG CGGGGCTGGG 181 GGCGGGGGGC GCACTCGGGC CCGCCCCTCT CTGCCCCACC CCCCTACTCG CCCTCCTCCA 241 CTTTTCTCCT CTTTTTTCCT TTCTCCACCT CTTTTCCCCG GCCGCCTGCT ACTCCTGGCC 301 TCTACGTCCA CCCTCAGTGC ACGACCTCGT CACCCCACTT GCCTCTCTCG CGATCTGGGC 361 GCACAGCCTC AGAACCCCCT GCTGGGAAAC ATCTGTCGCT CTAGGCCCTT GACGTCCTGA 421 GGTTAGAGAG CAGCGGTACT ACTAGGAGGG ACGCCGGCTT GGCTAGGACA CCCTGCACTC 481 CCTGGGGTCA GGAACGGGAA GGAATGGTCA GAAACAGATG ATCAGCCACA ATGATAGATG 541 GTCAGAGACA GAAATTTTCG ATATTTAGGG ATAGGGACAG AGAGATTCTG GGATGAACAG 601 AGATGGAAAG AGAGAGATGG AAACAGAGAC AGTGGAAGGT CCCAGGTTGC TTCCTTACCT 661 CTTTCCTTCT GCAAATGTGT AAGCCTTAAC TTGGCCTCGT ATAGTGCGAG ATGCTAGATA 721 CACCTTGGGA AATAGAGCAG TCAGGGGCCC CGCGTTAGAG ACGTTGGAAC CAGAGCGACT 781 CCATCTTGAA CAGGGGGCTG GGTAAAATGA GGCTGAGACC TGCTGGGCTG CACTCCCAGG 841 AGGGTCCGCA TTCTCGGTCA CAGGATGAGA TAGAAATTGG GCAAGACTGG TTTAATAAGA 901 TAGAGGTCAC AAAGACCCCC ACTGATAAAA CAGTATGCAG TGAAGAAGCC AGCCAAAACC 961 AAGATGGCAA AGAAAGCGAC CTCTGGTCAT CCTCACTGCT CATTTTACGC TAATTATAAT 1021 GCATTAGCAT GTTTAAAGGG AAGCACCCAC CAGTGCCCAT GGCCAGTGTA TAAATGGCCC 1081 ATTGCCAATG TGGGGGAGTT TTACCCTATA TGTCTAAAAA GGGTAGAGCC CCCTCCAGTT 1141 CCCCACGGAA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content